Related Experiment Video

Updated: Jun 29, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

First-in-human gene editing for lipid lowering: the initial results

Simon Tual-Chalot1, Konstantinos Stellos1,2,3,4,5

  • 1Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Centre for Life, Newcastle Upon Tyne NE1 3BZ, UK.

Cardiovascular Research
|March 30, 2024
PubMed
Summary

No abstract available in PubMed .

Keywords:
Atherosclerotic cardiovascular diseaseClinical trialGene editingLipid-lowering therapyPCSK9 inhibitor

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Concept Videos